GSTP1/2 Double Knockout Mouse

Double Knockout

GSTP1/2 Double Knockout Mouse Model
This line is cryopreserved and requires cryorecovery.

C57BL/6 Background

  • Model #
  • Genotype
  • Nomenclature
  • 14086-F
  • 14086-M
  • Double knockout of the glutathione S-transferase, pi 1 and glutathione S-transferase, pi 2 genes
  • The Gstp1/2 double knockout is useful for the in vivo study of a Gstp1/2 (regulator of protein synthesis/degradation) function in tumorigenesis, drug metabolism and toxicity.

Genetic Background:



The Gstp1/2 double knockout was developed in the laboratory of C. Roland Wolf at the Imperial Cancer Research Fund Molecular Pharmacology Unit, Dundee, United Kingdom. A Gstp1/2 targeting vector, replacing all of the Gstp1 gene and exons 6 and 7 of the Gstp2 gene with a resistance cassette, was transfected into E14Tg2a.IV ES cells. Properly targeted ES cells containing a homologous recombination event were selected, cloned, and injected into blastocysts. Chimeric mice were mated with MF1 mice to generate mice heterozygous for GSTP1/2 knockout. Heterozygous mice were interbred to generate mice homozygous for GSTP1/2 knockout. Founder lines were backcrossed to C57BL/6. Taconic received embryos from CRT in 2015.


Cancer Research Technology (CRT)



Initial Publication:

Henderson CJ et al. 1998. Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proceedings of the National Academy of Sciences USA. 95:5275-80.

Access to this model requires execution of a Limited Breeding Agreement and cryorecovery services to recover the line. Current Limited Breeding Agreement fees for this model are $2,500/year (€2000/year) for nonprofit users and $10,000/year (€8000) for for-profit users. Cryorecovery fees are additional.